TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MEDP

Medpace Holdings Inc

Healthcare · Diagnostics & Research

620.60$ +0.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

Medpace Holdings Inc (MEDP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 162 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MEDP
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
42 29 -0.7 30 39 29 23 41 53 39 34 47 64 57 49 44 60 105 57 63 72 71 46 97 108 137 80 83 114 156 153 116 149 191 126 149 246 193 152 162 753
15 15 12 12 12 12 9.7 9.6 9.7 9.7 7.8 5.0 5.1 5.3 4.5 4.7 4.9 5.5 5.1 5.2 5.3 5.5 5.1 5.5 5.8 5.9 6.0 6.5 6.9 7.0 7.0 7.2 7.5 7.5 6.9 7.0 6.3 7.1 6.9 6.7 27
4.3 1.3 1.0 1.2 1.0 1.2 1.5 1.5 1.4 2.1 3.2 5.4 9.5 2.7 5.4 2.6 2.8 3.0 2.9 3.6 4.0 4.0 4.4 5.7 5.8 5.6 5.4 4.9 5.0 5.2 4.3 3.6 12 5.9 17 6.0 6.3 5.6 4.9 4.3 21
– 11 0.4 0.3 1.6 -1.8 1.2 2.2 8.7 0.0 3.8 6.6 12 9.9 6.5 3.8 7.4 -3.4 4.3 8.8 8.6 -36 3.4 9.1 5.5 -17 2.9 2.8 4.0 – – – – – – – – – – – –
18 11 -21 8.9 16 9.5 -2.1 13 22 7.0 0.9 4.6 21 9.4 6.6 8.6 2.4 49 0.9 8.8 9.9 47 -28 33 27 75 -6.5 7.2 33 73 38 11 29 79 -19 5.6 87 22 -8.7 19 120
2.2 5.7 4.4 2.2 2.4 3.4 4.0 5.8 2.8 3.4 2.5 3.5 6.2 5.8 5.6 9.3 8.7 7.8 6.5 6.0 6.6 9.1 9.3 11 7.2 9.2 9.5 8.4 8.7 10.0 5.5 13 11 7.6 10.0 6.1 16 4.5 6.8 24 51
-2.1 -5.7 -4.4 -2.1 -2.3 -3.4 -3.9 -6.0 -2.8 -4.2 -3.8 -3.4 -6.1 -5.7 -5.5 -9.3 -8.6 -7.7 -9.7 -6.0 -6.6 -9.1 -11 -11 -7.2 -9.2 -9.5 -8.5 -8.7 -8.0 2.5 -13 -10 -7.6 -10.0 -6.0 -11 -4.5 -6.7 -24 -46
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – 5.8 2.5 1.7 – – – – – – – – – – – – –
174 174 0.2 -26 -69 -60 0.6 0.6 0.6 0.7 1.0 2.9 1.8 0.8 -42 -9.1 -51 -47 9.1 -56 -6.2 2.4 -426 -375 -426 -47 -120 -24 0.0 0.0 0.0 0.0 0.0 -170 -372 -541 -4.6 0.0 0.0 -295 -299
– -228 -3.5 -3.5 26 56 -25 -35 -50 -35 -24 -56 – – – – – – – – 250 250 250 250 -110 -90 65 -60 -55 – – – 0.0 0.0 – – – – – – –
-39 -3.1 -3.3 -29 -42 -23 -24 -34 -50 -34 -23 -54 1.8 0.8 -40 -8.4 6.8 -40 9.1 -51 -5.2 2.4 -412 -123 -109 -131 -53 -82 -49 1.5 7.7 0.7 6.3 -169 -346 -541 3.4 23 13 -288 -250
1.0 19 -7.8 -0.3 -5.1 2.2 -4.2 0.0 0.0 1.0 6.8 -10 59 53 2.1 27 58 59 55 6.1 59 63 -378 -40 -12 -2.7 19 -7.8 56 150 162 104 146 13 -228 -395 239 212 156 -150 456
40 23 -5.0 28 37 25 19 36 50 36 31 43 58 51 44 35 51 98 51 57 66 62 37 85 101 127 71 74 106 146 147 104 139 183 116 142 262 188 145 138 734

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?